The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.
about
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancerNeutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.A review of the application of inflammatory biomarkers in epidemiologic cancer research.Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinomaThe relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancerA novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour.A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)TGF-beta inhibitors for the treatment of cancer.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.A systematic review of the association between circulating concentrations of C reactive protein and cancerInflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer.Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians.Lack of association between -174G>C and -634C>G polymorphisms in interleukin-6 promoter region and lung cancer risk: a meta-analysis.Are tumoral factors responsible for host tissue wasting in cancer cachexia?High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.External validation of the modified Glasgow prognostic score for renal cancer.The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.Association between TNF-α gene 308G>A polymorphism and lung cancer risk: a meta-analysis.Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer.Adipokines and systemic inflammation in weight-losing lung cancer patients.Osteopontin as a marker of weight loss in lung cancer.Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.Development and validation of diagnostic prediction model for solitary pulmonary nodules.
P2860
Q24810591-6EF68FA5-8A75-43B3-8B20-12C0E7EB570AQ30847076-4797727E-C3D6-4C0B-A208-8083E2A4F4CBQ33684911-46E98908-12FA-448D-A5B7-D0C76F53DBFEQ33925759-35B1A868-538A-4663-8824-3170FDC846E1Q34096100-652C4850-E917-4DC2-A223-663FC37FD845Q34135803-30C0AC8F-4245-4DA1-9AE9-F18A241B024CQ34623313-AE2B93AA-66A0-4A94-9939-A56BC2A493D3Q35551037-AABC22A0-15C6-454C-A5FA-812F86F24C50Q35579236-CE2A552A-C3CA-4BC2-B2D2-C29FDA1FC6C3Q35863187-A28B2A1C-4171-49ED-B1CE-5335B277774CQ35889913-A228BCBD-4913-43F5-B5F8-9FD234909FE0Q36187040-A3E21A2F-4C2E-4548-B650-A546B768D4E2Q36611805-6114E5C0-0C96-41B8-9809-77346150535AQ36613615-12D474F4-165F-429A-A3B5-719C6ABAC522Q36731164-547C3DB5-DAA2-4FCC-9378-B466DBB4AF53Q36910671-546D97EF-335D-4815-B301-3C0C2E22764FQ37076331-C0A81630-D0FD-463C-BBBE-B22030141004Q37121339-9953427F-5813-4ADB-8B6B-6C94D8709115Q37144395-80CCDB75-F882-4D5C-B80B-DAEA5E410BC3Q37165610-B39F5150-F028-4226-A2DE-1402F8B9FFA7Q37366321-DAFCECA9-3786-475C-A954-410B16BF8643Q37464721-A8332D92-A72A-48A9-A16B-853A0E711C48Q38400592-F52C4881-0FEF-4A51-B6E2-9486C2950927Q39885110-FA65D65D-56D2-4D23-91F9-AB533FB95642Q40822344-A85A8F90-F019-443A-95B3-C79921C0A722Q41780002-2F36E6CE-68EA-4AAD-BCF4-2C8178272ECFQ41881543-4910FED6-BC16-494B-A1A9-2B5A7BA78CC7Q41900633-C01520D5-74B8-4DF3-B6E2-9E4BB7FC464DQ43644114-0D020EA7-DB72-4ED3-834C-689A77588CC9Q46173718-8074239F-99E2-4B5F-A957-191CBDC2FEF5Q46239362-8A984951-8C95-423F-A287-855729818D84Q47332106-9C4A6259-9B3E-48FE-969B-195ADB266290Q47348456-CE923035-46E7-43BD-9309-8FA974E1437DQ52952856-1731417C-6581-41BA-A6F0-9CF16ED0B674Q53454867-471FBC7A-ED0B-45F9-B079-9F17EA17A1E8
P2860
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The relationship between circu ...... th non-small-cell lung cancer.
@ast
The relationship between circu ...... th non-small-cell lung cancer.
@en
type
label
The relationship between circu ...... th non-small-cell lung cancer.
@ast
The relationship between circu ...... th non-small-cell lung cancer.
@en
prefLabel
The relationship between circu ...... th non-small-cell lung cancer.
@ast
The relationship between circu ...... th non-small-cell lung cancer.
@en
P2093
P2860
P356
P1476
The relationship between circu ...... th non-small-cell lung cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602248
P407
P577
2004-12-01T00:00:00Z
P5875
P6179
1028984363